Non-Biological Complex Drugs / Najlacnejšie knihy
Non-Biological Complex Drugs

Kód: 09205040

Non-Biological Complex Drugs

Autor Daan J. A. Crommelin, Jon S. B. de Vlieger

This book will review progress towards attaining a global consensus regarding the introduction of follow-on versions of non biological complex drugs (NBCD). A non biological complex drug is a medicinal product, not being a biologi ... celý popis

140


Skladom u dodávateľa v malom množstve
Odosielame za 10 - 15 dní

Potrebujete viac kusov?Ak máte záujem o viac kusov, preverte, prosím, najprv dostupnosť titulu na našej zákazníckej podpore.


Pridať medzi želanie

Mohlo by sa vám tiež páčiť

Darujte túto knihu ešte dnes
  1. Objednajte knihu a vyberte Zaslať ako darček.
  2. Obratom obdržíte darovací poukaz na knihu, ktorý môžete ihneď odovzdať obdarovanému.
  3. Knihu zašleme na adresu obdarovaného, o nič sa nestaráte.

Viac informácií

Viac informácií o knihe Non-Biological Complex Drugs

Nákupom získate 345 bodov

Anotácia knihy

This book will review progress towards attaining a global consensus regarding the introduction of follow-on versions of non biological complex drugs (NBCD). A non biological complex drug is a medicinal product, not being a biological medicine, where the active substance is not a homo-molecular structure but consists of different (closely related and often nano particulate) structures that cannot be isolated and fully quantitated, characterized and/or described by state-of-the-art physicochemical analytical means and where the clinical meaning of the differences is not known. The composition, quality and in vivo performance of NBCD are highly dependent on manufacturing processes of both the active ingredient as well as in most cases the formulation. The challenges posed by the development of follow-on versions of NBCD are illustrated in this book. It discusses how the same principles for the marketing authorization of copies of NBCD as for biosimilars could be used: the need for animal and/or clinical data and the need to show similarity in quality, safety and efficacy. The regulatory approach of NBCD will have to take into consideration the specific characteristics of the drugs, their formulation and manufacturing process and the resulting critical attributes to achieve their desired quality, safety and efficacy. As with the biosimilars, for the NBCD product, family-specific methods should be evaluated and applied where scientifically proven, including sophisticated quality methods, pharmacodynamic markers and animal models.

Parametre knihy

Zaradenie knihy Knihy po anglicky Technology, engineering, agriculture Industrial chemistry & manufacturing technologies Industrial chemistry

140

Obľúbené z iného súdka



Osobný odber Bratislava a 2642 dalších

Copyright ©2008-24 najlacnejsie-knihy.sk Všetky práva vyhradenéSúkromieCookies


Môj účet: Prihlásiť sa
Všetky knihy sveta na jednom mieste. Navyše za skvelé ceny.

Nákupný košík ( prázdny )

Vyzdvihnutie v Zásielkovni
zadarmo nad 59,99 €.

Nachádzate sa: